UC to host poet laureate
UC graduate and poet Manuel Iris will give a reading of his work at UC's Engineering Research Center at 7 p.m. Wednesday
Event Information (passed)
University of Cincinnati graduate and Cincinnati poet laureate Manuel Iris will return to UC for a poetry reading at the College of Engineering and Applied Science.
Iris will present "Translating Silence/Traducir el Silencio," a bilingual poetry reading from 7 to 9 p.m. Wednesday, Jan. 30, at the Engineering Research Center, Room 427.
The presentation is sponsored by UC's Departments of English and of Romance and Arabic Languages and Literatures.
Iris, a teacher at Cincinnati's DePaul Cristo Rey High School, has published six books of poetry and in 2018 was named the poet laureate of Cincinnati.
Iris is the winner of Mexico's National Award of Poetry Merida for his book "Notebook of Dreams." His latest book is titled "Overnight Medley."
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.